Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00943202Phase 2Completed
A Phase 2 trial of Influenza A (H1N1) vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00943202.